International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis

BJU International

Volumn 110, Issue 5, 2012, Pages 674-681

  Roscigno, Marco ^b   Cha, Eugene K ^a   Rink, Michael ^a,j   Seitz, Christian ^f   Novara, Giacomo ^c   Chromecki, Thomas F ^a,g   Fritsche, Hans Martin ⁱ   Matsumoto, Kazumasa ^k   Walton, Thomas J ^l   Carballido, Joaquin ^m   Filippo Da Pozzo, Luigi ^b   Bertini, Roberto ^d   Ficarra, Vincenzo ^c   Otto, Wolfgang ⁱ   Karakiewicz, Pierre I ⁿ   Pycha, Armin ^e   Fajkovic, Harun ^a,h   Naspro, Richard ^b   Scherr, Douglas S ^a   Montorsi, Francesco ^d   Shariat, Shahrokh F ^a   more..

^a New York Presbyterian Hospital ^*  (United States)

^b OSPEDALI RIUNITI   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e CENTRAL HOSPITAL OF BOLZANO   (Italy)

^f St John of God Hospital   (Austria)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

^h General Hospital St Poelten   (Austria)

ⁱ UNIVERSITY OF REGENSBURG   (Germany)

^j UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^k KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^m HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

ⁿ UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

prognosis; survival; TNM staging; upper urinary tract; urothelial carcinoma

Indexed keywords

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; ASIA; CANCER CLASSIFICATION; CANCER GRADING; CANCER INFILTRATION; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; EUROPE; FEMALE; HUMAN; KIDNEY PARENCHYMA; KIDNEY PELVIS CARCINOMA; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; NORTH AMERICA; PATHOLOGIST; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84865345750     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.10930.x     Document Type: Article

References (22)

1. Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer. TNM Classification of Malignant Tumours, 7th edn. Chichester, Hoboken, NJ: Wiley-Blackwell, 2010
2. Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009; 115: 1224-33
3. Komatsu H, Tanabe N, Kubodera S, Maezawa H, Ueno A,. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract. J Urol 1997; 157: 1622-4 (Pubitemid 27171738)
4. Langner C, Hutterer G, Chromecki T, Winkelmayer I, Rehak P, Zigeuner R,. pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract. Mod Pathol 2006; 19: 272-9 (Pubitemid 43117612)
5. Yoshimura K, Arai Y, Fujimoto H, et al. Prognostic impact of extensive parenchymal invasion pattern in pT3 renal pelvic transitional cell carcinoma. Cancer 2002; 94: 3150-6 (Pubitemid 34670498)
6. Olgac S, Mazumdar M, Dalbagni G, Reuter VE,. Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol 2004; 28: 1545-52 (Pubitemid 39564958)
7. Wu CF, Pang ST, Chen CS, Chuang CK, Chen Y, Lin PY,. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma. J Urol 2007; 178: 446-50 (Pubitemid 47030495)
8. Cho KS, Cho DS, Choi YD, Hong SJ, Kim SJ, Cho NH,. A proposal for a novel staging system in renal pelvicaliceal urothelial carcinomas. Hum Pathol 2007; 38: 1639-48 (Pubitemid 47589086)
9. Shariat SF, Zigeuner R, Rink M, et al. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. Eur Urol 2012; doi:10.1016/j.eururo.2012.01.019
10. Epstein JI, Amin MB, Reuter VR, Mostofi FK,. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 1435-48 (Pubitemid 28550639)
11. Remzi M, Haitel A, Margulis V, et al. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 2009; 103: 307-11
12. Kikuchi E, Margulis V, Karakiewicz PI, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 2009; 27: 612-18
13. Zigeuner R, Shariat SF, Margulis V, et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 2010; 57: 575-81
14. Raman JD, Ng CK, Scherr DS, et al. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 2010; 57: 1072-9
15. Peduzzi P, Concato J, Feinstein AR, Holford TR,. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995; 48: 1503-10 (Pubitemid 26035533)
16. Bastian PJ, Hutterer GC, Shariat SF, et al. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival. BJU Int 2008; 101: 450-4 (Pubitemid 351160922)
17. Boudreaux KJ Jr, Chang SS, Lowrance WT, et al. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Cancer 2009; 115: 770-5
18. Tilki D, Svatek RS, Karakiewicz PI, et al. pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder. J Urol 2010; 184: 470-4
19. Sonpavde G, Khan MM, Svatek RS, et al. Prognostic Risk Stratification of Pathological Stage T3N0 Bladder Cancer After Radical Cystectomy. J Urol 2011; 185: 1216-21
20. Hellenthal NJ, Shariat SF, Margulis V, et al. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the upper tract urothelial carcinoma collaboration. J Urol 2009; 182: 900-6
21. Roscigno M, Brausi M, Heidenreich A, et al. Lymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer. Eur Urol 2011; 60: 776-84
22. Margulis V, Youssef RF, Karakiewicz PI, et al. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 2010; 184: 453-8